- $1.38bn
- $1.60bn
- $627.12m
- 59
- 70
- 43
- 59
2019 December 31st | 2020 December 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 167 | 210 | 513 | 628 | 627 |
Cost of Revenue | |||||
Gross Profit | -23.5 | 24.7 | 123 | 117 | 147 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 469 | 350 | 645 | 1,239 | 1,997 |
Operating Profit | -302 | -140 | -132 | -610 | -1,370 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -330 | -277 | -345 | -441 | -1,450 |
Provision for Income Taxes | |||||
Net Income After Taxes | -321 | -271 | -336 | -434 | -1,443 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -321 | -271 | -367 | -477 | -1,453 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -321 | -271 | -367 | -477 | -1,453 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.66 | -2.14 | -1.37 | -0.459 | -1.29 |